A detailed history of Everpar Advisors LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Everpar Advisors LLC holds 1,411 shares of ZTS stock, worth $248,547. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,411
Previous 1,525 7.48%
Holding current value
$248,547
Previous $264 Million 4.28%
% of portfolio
0.14%
Previous 0.13%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$172.58 - $196.48 $19,674 - $22,398
-114 Reduced 7.48%
1,411 $276 Million
Q2 2024

Jul 18, 2024

BUY
$145.54 - $178.83 $221,948 - $272,715
1,525 New
1,525 $264 Million
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $227,008 - $299,934
1,499 New
1,499 $296 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.5B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Everpar Advisors LLC Portfolio

Follow Everpar Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Everpar Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Everpar Advisors LLC with notifications on news.